QPPV.COM KNOWLEDGE ASSESSMENT

XEVMPD Lifecycle Maintenance: Variations, Transfers, Renewals, Suspensions, Withdrawals and Pharmacovigilance Information

Test your understanding of the concepts covered by Maintaining XEVMPD Through the Product Lifecycle: Variations, Transfers, Renewals, Suspensions and Withdrawals.

Question 1 of 10Pass mark: 80%

Question 1 of 10 What is the most appropriate interpretation of the transition toward Product Management Services and ISO IDMP-related environments?

Lifecycle-control principles become unnecessary because the technology will manage all decisions automatically Only the user interface changes; no regulatory or data processes require review Technology and interfaces may evolve, but the need for accurate, current and traceable product information remains Article 57 maintenance obligations end immediately when a new interface is introduced

Question 2 of 10 Which control most directly addresses the difference between event identification and population identification?

Maintaining a controlled product list linked to the event and reconciling expected versus actual records Submitting an XEVPRM for the first product found in the regulatory system Relying on the most experienced data-entry specialist Checking only whether the regulatory decision has been archived

Question 3 of 10 After a major portfolio transfer, which reconciliation result provides the clearest evidence of population traceability?

The vendor confirms that at least one product was updated The number of products submitted is compared with the expected population, and each product's final state is verified The regulatory team confirms that the transfer was legally effective The organisation archives the transfer letter without comparing product records

Question 4 of 10 What is the most appropriate role of a regulatory event register in lifecycle maintenance?

To replace the official regulatory record To provide traceability from the event through impact assessment, submission, verification and closure To record only events that definitely require an XEVPRM To serve as a list of products that have been withdrawn from the market

Question 5 of 10 What is the most accurate description of an MAH's Article 57 XEVMPD obligation?

To submit product information once when the marketing authorisation is granted To maintain submitted information so that it reflects the current regulatory state To update XEVMPD only when a safety signal is identified To replace the national product database with XEVMPD

Question 6 of 10 Why should revocation and withdrawal not be treated as interchangeable internal status labels?

They are always handled by different software systems The underlying regulatory events may differ and the applicable decision and guidance should determine the maintenance Neither event has any relevance to Article 57 data Withdrawal always means that the marketing authorisation has been revoked

Question 7 of 10 After a transfer, 29 of 30 expected product records have been updated. What should the investigation focus on first?

Whether the missing product should be permanently removed Whether the product was excluded because the population-identification method was incomplete Whether the transfer procedure should be restarted for all products Whether acknowledgement of the 29 submissions proves that the process was effective

Question 8 of 10 A company receives approval for a variation that changes the manufacturing site but does not alter any information represented in the Article 57 data set. What is the most appropriate XEVMPD action?

Submit an XEVPRM automatically because every approved variation requires one Delete and recreate the medicinal-product record Document the impact assessment and conclude that no XEVMPD medicinal-product update is required Wait until the next renewal before considering the change

Question 9 of 10 A company discovers that one transferred product was missed because it used a separate internal product code. What is the most valuable corrective action beyond fixing that record?

Assume the error was isolated because the other records were updated Review whether the population-identification method systematically excludes similarly coded products Delete the separate product code from all systems without assessment Limit future transfers to single-product transactions

Question 10 of 10 Which scenario best illustrates a wrong-data-element failure?

The regulatory event was never communicated to the XEVMPD team The affected product population was incomplete The correct product was identified, but an unrelated field was changed instead of the field affected by the variation The submission was processed and then verified against the regulatory decision

QPPV.com

XEVMPD Lifecycle Maintenance: Variations, Transfers, Renewals, Suspensions, Withdrawals and Pharmacovigilance Information

Cookie Settings